Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Don S Dizon

Showing results (1-10 of 216) with videos related to

Pageof 22
Sort By:
The Breast Journal|July 21, 2009
Quality of life after breast cancer: survivorship and sexualityDon S Dizon
Cancer Investigation|January 12, 2005
Incorporating targeted treatments into standard regimens: whither the role of established doses?Don S Dizon
The Oncologist|June 28, 2014
Narratives in oncologyDon S Dizon
Lancet (London, England)|September 17, 2017
PARP inhibitors for targeted treatment in ovarian cancerDon S Dizon
The Oncologist|September 12, 2014
My Father's Final LessonDon S Dizon
CA: a Cancer Journal for Clinicians|January 27, 2024
Becoming the new editor for CA: The future is nowDon S Dizon
The Oncologist|July 26, 2017
What's the Harm?Don S Dizon
The Oncologist|April 12, 2014
Guilt and the burden on oncology providersDon S Dizon
American Journal of Clinical Oncology|May 10, 2011
Where do antiangiogenic agents belong in the treatment algorithm for ovarian cancer?Don S Dizon
Gynecologic Oncology|March 13, 2010
Treatment options for advanced endometrial carcinomaDon S Dizon
Pageof 22

Showing results (1-10 of 216) with videos related to

Sort By:
Pageof 22
The Breast Journal|July 21, 2009
Quality of life after breast cancer: survivorship and sexualityDon S Dizon
Cancer Investigation|January 12, 2005
Incorporating targeted treatments into standard regimens: whither the role of established doses?Don S Dizon
The Oncologist|June 28, 2014
Narratives in oncologyDon S Dizon
Lancet (London, England)|September 17, 2017
PARP inhibitors for targeted treatment in ovarian cancerDon S Dizon
The Oncologist|September 12, 2014
My Father's Final LessonDon S Dizon
CA: a Cancer Journal for Clinicians|January 27, 2024
Becoming the new editor for CA: The future is nowDon S Dizon
The Oncologist|July 26, 2017
What's the Harm?Don S Dizon
The Oncologist|April 12, 2014
Guilt and the burden on oncology providersDon S Dizon
American Journal of Clinical Oncology|May 10, 2011
Where do antiangiogenic agents belong in the treatment algorithm for ovarian cancer?Don S Dizon
Gynecologic Oncology|March 13, 2010
Treatment options for advanced endometrial carcinomaDon S Dizon
Pageof 22